Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Xiwei Pharmaceutical Technology is a China-based biotechnology company specializing in pharmaceutical research and development services. Founded in 2016 and headquartered in Chongqing, the company focuses on the synthesis of high-end pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and the development of small molecule drug candidates. Xiwei Pharmaceutical provides comprehensive CRO services, including process chemistry, medicinal chemistry, and lead optimization for domestic and international pharmaceutical partners. Their technical expertise is primarily applied within the therapeutic areas of oncology and metabolic disorders, supporting the transition of innovative molecules from discovery to early-stage development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Xiwei Pharmaceutical Technology.